A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.


Genome-wide association studies (GWAS) have identified ∼30 single-nucleotide polymorphisms (SNPs) consistently associated with prostate cancer (PCa) risk. To test the hypothesis that other sequence variants in the genome may interact with those 32 known PCa risk-associated SNPs identified from GWAS to affect PCa risk, we performed a systematic evaluation… (More)
DOI: 10.1093/carcin/bgr316


3 Figures and Tables